Abstract A17: Novel patient-derived xenograft (PDX) models from peritoneal metastasis of colorectal carcinoma for drug testing and biomarker analysis

作者
Wolfgang Walther,Eva Pachmayr,Bernadette Brzezicha,Britta Büttner,Beate Rau,Ulrike Stein
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:78 (10_Supplement): A17-A17
标识
DOI:10.1158/1538-7445.mousemodels17-a17
摘要

Abstract Peritoneal metastasis (PM) represents a terminal tumor stage with limited therapy options for patients with colorectal cancer (CRC). To improve therapeutic efficacy and overall survival, availability of appropriate in vivo models of PM could improve the evaluation of chemosensitivity as well as identification of novel biomarkers and therapeutic targets to improve the therapeutic outcome of PM patients. In this context, we generated the first patient-derived xenograft (PDX) models of PM from CRC as platform to test chemotherapy response and to potentially analyze biomarkers. For the PDX establishment colorectal surgical specimens were subcutaneously (s.c.) transplanted onto immunocompromised NOG mice. The engrafted tumors were transferred to NMRI nu/nu mice for further passaging. They were characterized by histopathology, immunohistochemistry, and gene expression analyses using real-time RT-PCR. Chemosensitivity of PDX models was evaluated in vivo by application of a panel of conventional chemotherapeutic and of targeted drugs. For PDX establishment 68 CRC surgical specimens (taken from peritoneum and omentum) were transplanted, from which 22 PDX have engrafted. From those, 13 models of 10 patients have been analyzed. Their tumor doubling times ranged between 4 to 28 days. The histopathologic evaluation revealed maintenance of the original CRC histology in the PDX. The chemosensitivity testing of conventional and of targeted drugs in the 13 PM PDX models revealed the individual, diverging response of the PDX, such as for 5-FU, irinotecan, oxaliplatin, cetuximab, and erlotinib. More interestingly, different responses were observed in PDX of the omentum vs. peritoneum, which were derived from the same patient. Our results demonstrate that this novel panel of PDX maintains the morphology of the patient tumor in early passages, reflect heterogeneous response rates, and can be used as a preclinical in vivo platform for translational studies of potential clinical use. In conclusion, this PDX panel of PM of the CRC can be used for further studies to evaluate new biomarkers and to test novel therapies or combinations for PM of CRC. Citation Format: Wolfgang Walther, Eva Pachmayr, Bernadette Brzezicha, Britta Büttner, Beate Rau, Ulrike Stein. Novel patient-derived xenograft (PDX) models from peritoneal metastasis of colorectal carcinoma for drug testing and biomarker analysis [abstract]. In: Proceedings of the AACR Special Conference: Advances in Modeling Cancer in Mice: Technology, Biology, and Beyond; 2017 Sep 24-27; Orlando, Florida. Philadelphia (PA): AACR; Cancer Res 2018;78(10 Suppl):Abstract nr A17.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhhhhhhh完成签到,获得积分10
刚刚
nfnf发布了新的文献求助10
1秒前
just发布了新的文献求助10
1秒前
曾经的安雁完成签到 ,获得积分10
1秒前
香蕉觅云的应助被蟹老板的crab采纳,获得10
1秒前
2秒前
河马大王发布了新的文献求助30
2秒前
童金炜完成签到,获得积分10
2秒前
小杨爱科研完成签到,获得积分20
2秒前
qianzhihe发布了新的文献求助10
3秒前
3秒前
3秒前
科研通AI6.3的应助被蔚雨采纳,获得10
3秒前
3秒前
4秒前
不吃香菜发布了新的文献求助10
4秒前
aiy发布了新的文献求助10
5秒前
含蓄的笙完成签到 ,获得积分10
5秒前
yyd完成签到,获得积分10
5秒前
研友_VZG7GZ的应助被学术智子采纳,获得10
6秒前
WangZhida发布了新的文献求助30
6秒前
6秒前
jing的应助被开心德地采纳,获得10
6秒前
HHHHH完成签到 ,获得积分10
6秒前
7秒前
7秒前
Orange的应助被一直小学生采纳,获得10
7秒前
龙仔完成签到,获得积分10
7秒前
八千代发布了新的文献求助10
7秒前
8秒前
Drcai发布了新的文献求助10
8秒前
Carlotta完成签到,获得积分10
8秒前
tyluo发布了新的文献求助30
9秒前
Reese发布了新的文献求助10
9秒前
10秒前
10秒前
晨晨发布了新的文献求助20
10秒前
LL完成签到 ,获得积分10
10秒前
领导范儿的应助被比巴卜采纳,获得10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187707
求助须知:如何正确求助?哪些是违规求助? 9575782
关于积分的说明 21843037
捐赠科研通 7785576
什么是DOI,文献DOI怎么找? 3435097
关于科研通互助平台的介绍 2559495
邀请新用户注册赠送积分活动 2481986